1066
Dr K.L. Jagan Babu
Dr K L Jagan Babu
Rheumatology : Rheumatology & Immunology
Experience: 3+ Years
Education: MBBS, MD, DNB, DM Rheumatology (JIPMER)
icon
Tamil Malayalam English Hindi
icon
10:00 - 14:00 MON - SAT
Book Appointment
Hospital
Select Date
Loading available days...
Available Slots
×
About Dr K L Jagan Babu

Dr. K.L. Jagan Babu is a highly skilled and accomplished rheumatologist with extensive training and expertise in autoimmune and inflammatory conditions. With an MBBS from Madurai Medical College, MD from Tirunelveli Medical College, and a DM in Rheumatology from JIPMER, Puducherry, Dr. K.L. Jagan Babu has honed a deep understanding of complex diseases like Rheumatoid Arthritis, Spondyloarthritis, and Systemic Lupus Erythematosus (SLE). As a lifetime member of the Indian Rheumatology Association, Dr. K.L. Jagan Babu has been recognized with numerous awards, including multiple prizes for presentations at prestigious conferences like IRACON and CRC. Passionate about research, Dr. K.L. Jagan Babu has published work in journals such as the American Journal of Tropical Medicine and Hygiene and the British Society for Rheumatology, focusing on lupus nephritis, scleroderma, and the use of biologic therapies. Specializing in early diagnosis, personalized care, and the safe use of biologics, Dr. K.L. Jagan Babu is also experienced in managing rheumatic diseases in pregnancy and other sensitive patient populations.

Read More icon
Experience
MBBS- Madurai Medical College
MD- Tirunelveli Medical College and Hospital
DNB- National Board of Examination
DM Rheumatology- JIPMER, Puducherry

Special interest

Early diagnosis and treatment of inflammatory arthritis
Personalised care for Rheumatoid Arthritis, Spondyloarthritis and Lupus
Expert in managing SLE with kidney involvement (lupus nephritis)
Expert in managing myositis and scleroderma with raynauds, ILD, PAH
Care for young women with autoimmune diseases planning pregnancy
Rheumatic manifestations in pregnancy and reproductive-age women
Rheumatic manifestations in patients with malignancy and undergoing chemotherapy
Treatment of vasculitis and autoinflammatory syndromes
Focus on safe use of biologic injections (e.g., Rituximab, Tocilizumab, Adalimumab)
Use of ultrasound in joint and soft tissue disease evaluation
Skilled in reading advanced lab tests like ANA, ENA, and other autoantibodies in SLE, Myositis and scleroderma

Memberships

membership-slide-cover
Indian Rheumatology Association Lifetime Member (LM-1585)

Awards & Achievements

Awarded First prize in the popular Internal Medicine Quiz on ECG at Tirunelveli, India
awards-icon
Awarded First prize in the poster presentation on “An effective treatment for CANDLE syndrome” 38th Annual Conference of Indian Rheumatology Association (IRACON) 2023, Hyderabad, India
awards-icon
Awarded Second prize in the poster presentation on “Intestinal Pseudo Obstruction (IPO) as initial presentation in SLE” 38th Annual Conference of Indian Rheumatology Association (IRACON) 2023, Hyderabad, India
awards-icon
Awarded First prize in the oral presentation on “Young stroke with multiple aneurysms: unraveling the diagnostic challenge” The Clinical Rheumatology Conference 2024 (CRC 2024), Secunderabad, Hyderabad, India
awards-icon
Awarded Second prize in the oral presentation on “An effective treatment for CANDLE syndrome” The Clinical Rheumatology Conference 2024 (CRC 2024), Secunderabad, Hyderabad, India
awards-icon

Research & Publications

01
Case series: The overlapping spectrum of primary tubercular myositis and immune mediated myositis: diagnostic challenges in three cases (American journal of tropical medicine and Hygiene)
02
Jose A, Gopal A, Kumari L, Jagan Babu KL, Jinkala S, Gorijavolu M, Gayathri MS, Kavadichanda C, Thabah MM. The Overlapping Spectrum of Primary Tubercular Myositis and Immune-Mediated Myositis: Diagnostic Challenges in Three Cases. Am J Trop Med Hyg. 2025 May 27:tpmd240546. doi: 10.4269/ajtmh.24-0546. Epub ahead of print. PMID: 40424996.
03
Epidemiology and classification criteria of systemic sclerosis chapter in Rheumatology manual book
04
Clinical outcomes and predictors of difficult-to-treat lupus nephritis: observations from a single center retrospective cohort (Author)- published oral abstract (OA21) in Oxford Academic Rheumatology website by British Society for Rheumatology (BSR)(https://doi.org/10.1093/rheumatology/keae163.021)
05
Estimation of nephron numbers and its change with induction therapy in lupus nephritis: a prospective observational study (Author)
06
Long-term safety outcomes and predictors of serious infections among patients with Systemic Lupus Erythematosus treated with Rituximab (Co-author)
07
Ultrasonographic assessment of vascular intimal-medial thickness for monitoring disease activity in Takayasu arteritis: A prospective observational study (Co-author)
08
Prevalence and characteristics of malignancy in dermatomyositis patients: An Indian cohort study (Co-author)
image image
Request a Callback
Request A Call Back
Request Type